Terms: = Sarcomas AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Treatment
118 results:
1. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
2. Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models.
Hu J; Lazar AJ; Ingram D; Wang WL; Zhang W; Jia Z; Ragoonanan D; Wang J; Xia X; Mahadeo K; Gorlick R; Li S
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199607
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel-resistant cutaneous angiosarcoma: Phase II study protocol.
Fujimura T; Yoshino K; Nakamura M; Kato H; Ito T; Maekawa T; Fujisawa Y; Matsushita S; Amagai R; Yamazaki E; Takahashi M; Tamabuchi E; Hashimoto A; Kambayashi Y; Yamazaki N; Miyata T; Asano Y
Exp Dermatol; 2024 Jan; 33(1):e14976. PubMed ID: 37946551
[TBL] [Abstract] [Full Text] [Related]
4. Next generation sequencing uncovers multiple miRNAs associated molecular targets in gallbladder cancer patients.
Saxena R; Chakrapani B; Sarath Krishnan MP; Gupta A; Gupta S; Das J; Gupta SC; Mirza AA; Rao S; Goyal B
Sci Rep; 2023 Nov; 13(1):19101. PubMed ID: 37925508
[TBL] [Abstract] [Full Text] [Related]
5. Radiotherapy and long-term sequelae in pediatric patients with parameningeal rhabdomyosarcoma: Results of two Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M; Dietzschold M; Schönstein A; Heinz A; Vokuhl C; Pajtler KW; Harrabi S; Lin YL; Kalle TV; Hagen R; Ladenstein R; Kazanowska B; Ljungman G; Klingebiel T; Ebinger M; Koscielniak E; Münter M; Timmermann B;
Pediatr Blood Cancer; 2024 Jan; 71(1):e30742. PubMed ID: 37880926
[TBL] [Abstract] [Full Text] [Related]
6. Differentiation between Phyllodes Tumors and Fibroadenomas through Breast Ultrasound: Deep-Learning Model Outperforms Ultrasound Physicians.
Shi Z; Ma Y; Ma X; Jin A; Zhou J; Li N; Sheng D; Chang C; Chen J; Li J
Sensors (Basel); 2023 May; 23(11):. PubMed ID: 37299826
[TBL] [Abstract] [Full Text] [Related]
7. Inferior Clinical Outcomes of Pediatric Rhabdomyosarcoma in Thailand: A 16-Year Experience in a Single Tertiary Institution.
Preechawetchakul P; Sripornsawan P; Rajborirug S; Sangkhathat S; Sangsupavanich P; Chotsampancharoen T
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2805-2811. PubMed ID: 36037137
[TBL] [Abstract] [Full Text] [Related]
8. Iron plays a role in sulfasalazine-induced ferroptosis with autophagic flux blockage in K7M2 osteosarcoma cells.
Liu J; Lou C; Zhen C; Wang Y; Shang P; Lv H
Metallomics; 2022 May; 14(5):. PubMed ID: 35441682
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes.
Qi W; Yan Q; Lv M; Song D; Wang X; Tian K
Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109
[No Abstract] [Full Text] [Related]
10. Geranylgeranylacetone promotes human osteosarcoma cell apoptosis by inducing the degradation of PRMT1 through the E3 ubiquitin ligase CHIP.
Jiang L; Liao J; Liu J; Wei Q; Wang Y
J Cell Mol Med; 2021 Aug; 25(16):7961-7972. PubMed ID: 34155784
[TBL] [Abstract] [Full Text] [Related]
11. Return to Work and Employment Situation of Young Adult Cancer Survivors: Results from the Adolescent and Young Adult-Leipzig Study.
Leuteritz K; Friedrich M; Sender A; Richter D; Mehnert-Theuerkauf A; Sauter S; Geue K
J Adolesc Young Adult Oncol; 2021 Apr; 10(2):226-233. PubMed ID: 32746763
[No Abstract] [Full Text] [Related]
12. The Histone Deacetylase Inhibitor Entinostat/Syndax 275 in Osteosarcoma.
Kiany S; Harrison D; Gordon N
Adv Exp Med Biol; 2020; 1257():75-83. PubMed ID: 32483732
[TBL] [Abstract] [Full Text] [Related]
13. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Doebele RC; Drilon A; Paz-Ares L; Siena S; Shaw AT; Farago AF; Blakely CM; Seto T; Cho BC; Tosi D; Besse B; Chawla SP; Bazhenova L; Krauss JC; Chae YK; Barve M; Garrido-Laguna I; Liu SV; Conkling P; John T; Fakih M; Sigal D; Loong HH; Buchschacher GL; Garrido P; Nieva J; Steuer C; Overbeck TR; Bowles DW; Fox E; Riehl T; Chow-Maneval E; Simmons B; Cui N; Johnson A; Eng S; Wilson TR; Demetri GD;
Lancet Oncol; 2020 Feb; 21(2):271-282. PubMed ID: 31838007
[TBL] [Abstract] [Full Text] [Related]
14. Focal adhesion kinase confers pro-migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma.
Steinestel K; Trautmann M; Jansen EP; Dirksen U; Rehkämper J; Mikesch JH; Gerke JS; Orth MF; Sannino G; Arteaga MF; Rossig C; Wardelmann E; Grünewald TGP; Hartmann W
Mol Oncol; 2020 Feb; 14(2):248-260. PubMed ID: 31811703
[TBL] [Abstract] [Full Text] [Related]
15. Hypertension prevalence and risk factors among residents of four slum communities: population-representative findings from Port-au-Prince, Haiti.
Tymejczyk O; McNairy ML; Petion JS; Rivera VR; Dorélien A; Peck M; Seo G; Walsh KF; Fitzgerald DW; Peck RN; Joshi A; Pape JW; Nash D
J Hypertens; 2019 Apr; 37(4):685-695. PubMed ID: 30817448
[TBL] [Abstract] [Full Text] [Related]
16. Radiation-associated sarcoma after breast cancer in a nationwide population: Increasing risk of angiosarcoma.
Salminen SH; Sampo MM; Böhling TO; Tuomikoski L; Tarkkanen M; Blomqvist CP
Cancer Med; 2018 Sep; 7(9):4825-4835. PubMed ID: 30044058
[TBL] [Abstract] [Full Text] [Related]
17. Recombinant methioninase in combination with doxorubicin (DOX) overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma.
Igarashi K; Kawaguchi K; Li S; Han Q; Tan Y; Murakami T; Kiyuna T; Miyake K; Miyake M; Singh AS; Eckardt MA; Nelson SD; Russell TA; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Singh SR; Eilber FC; Hoffman RM
Cancer Lett; 2018 Mar; 417():168-173. PubMed ID: 29306021
[TBL] [Abstract] [Full Text] [Related]
18. MSP-4, an Antimicrobial Peptide, Induces Apoptosis via Activation of Extrinsic fas/fasL- and Intrinsic Mitochondria-Mediated Pathways in One Osteosarcoma Cell Line.
Kuo HM; Tseng CC; Chen NF; Tai MH; Hung HC; Feng CW; Cheng SY; Huang SY; Jean YH; Wen ZH
Mar Drugs; 2018 Jan; 16(1):. PubMed ID: 29301308
[TBL] [Abstract] [Full Text] [Related]
19. Chemosensitive effects of Astragaloside IV in osteosarcoma cells via induction of apoptosis and regulation of caspase-dependent fas/fasL signaling.
Hu T; Fei Z; Wei N
Pharmacol Rep; 2017 Dec; 69(6):1159-1164. PubMed ID: 29128795
[TBL] [Abstract] [Full Text] [Related]
20. Combination of Cinobufacini and Doxorubicin Increases Apoptosis of Hepatocellular Carcinoma Cells through the fas- and Mitochondria-Mediated Pathways.
Xia J; Inagaki Y; Gao J; Qi F; Song P; Han G; Sawakami T; Gao B; Luo C; Kokudo N; Hasegawa K; Sakamoto Y; Tang W
Am J Chin Med; 2017; 45(7):1537-1556. PubMed ID: 28946772
[TBL] [Abstract] [Full Text] [Related]
[Next]
